2022
DOI: 10.1055/s-0041-1740340
|View full text |Cite
|
Sign up to set email alerts
|

Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia

Abstract: Global emergence of multidrug-resistant and extensive drug-resistant gram-negative bacteria has increased the risk of treatment failure, especially for healthcare- or ventilator-associated pneumonia (HAP/VAP). Nebulization of antibiotics, by providing high intrapulmonary antibiotic concentrations, represents a promising approach to optimize the treatment of HAP/VAP due to multidrug-resistant and extensive drug-resistant gram-negative bacteria, while limiting systemic antibiotic exposure. Aminoglycosides and co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 102 publications
(211 reference statements)
0
2
0
Order By: Relevance
“…In addition, our results cannot be generalized for geographical areas with a high prevalence of carbapenemases, and further studies are required, with important implications for stewardship or preventive strategies. The implications for antimicrobial stewardship or VAP prevention are beyond the scope of this article, and we refer the readers to recent updates [ 2 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ] addressing these important issues.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, our results cannot be generalized for geographical areas with a high prevalence of carbapenemases, and further studies are required, with important implications for stewardship or preventive strategies. The implications for antimicrobial stewardship or VAP prevention are beyond the scope of this article, and we refer the readers to recent updates [ 2 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ] addressing these important issues.…”
Section: Discussionmentioning
confidence: 99%
“…The rise in drug-resistant gram-negative pathogens, such as extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Enterobacteriaceae, has been associated with treatment failures and increased mortality in ICU patients [ 2 ]. To address this issue, the use of adjunctive inhaled antibiotics has emerged as a viable strategy [ 3 ]. Inhaled antibiotics offer the advantage of achieving higher drug concentrations in the pulmonary epithelial cells, which is particularly beneficial for treating gram-negative infections with aminoglycosides [ 4 ].…”
Section: Introductionmentioning
confidence: 99%